STAAR Surgical Co Finance Lease, Right-of-Use Asset, Amortization
STAAR Surgical Co (STAA) reported Finance Lease, Right-of-Use Asset, Amortization of $147.00 thousand for the 12-month period ending 2024-12-27, per its 10-K filed 2025-02-21.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2025-02-21
- STAAR Surgical Co finance lease, right-of-use asset, amortization for the quarter ending 2024-12-27 was $37.00K, a 0.00% change year-over-year.
- STAAR Surgical Co finance lease, right-of-use asset, amortization for the quarter ending 2024-09-27 was $36.00K, a 2.70% decline year-over-year.
- STAAR Surgical Co finance lease, right-of-use asset, amortization for the quarter ending 2024-06-28 was $37.00K, a 2.63% decline year-over-year.
- STAAR Surgical Co finance lease, right-of-use asset, amortization for the quarter ending 2024-03-29 was $37.00K, a 5.13% decline year-over-year.
- STAAR Surgical Co finance lease, right-of-use asset, amortization for fiscal 2024 was $147.00K, a 2.65% decline from fiscal 2023.
- STAAR Surgical Co finance lease, right-of-use asset, amortization for fiscal 2023 was $151.00K, a 5.63% decline from fiscal 2022.
- STAAR Surgical Co finance lease, right-of-use asset, amortization for fiscal 2022 was $160.00K, a 92.77% increase from fiscal 2021.
- STAAR Surgical Co finance lease, right-of-use asset, amortization for fiscal 2021 was $83.00K, a 67.95% decline from fiscal 2021.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 6 month | Finance Lease, Right-of-Use Asset, Amortization 9 month | Finance Lease, Right-of-Use Asset, Amortization 12 month |
|---|---|---|---|---|
| 2024-12-27 | $37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | $73.00K derived: sum of 2 quarters · filed 2025-02-21 | $110.00K derived: sum of 3 quarters · filed 2025-02-21 | $147.00K 10-K · filed 2025-02-21 |
| 2024-09-27 | $36.00K 10-Q · filed 2024-10-30 | $73.00K derived: sum of 2 quarters · filed 2024-10-30 | $110.00K 10-Q · filed 2024-10-30 | $147.00K derived: sum of 4 quarters · filed 2025-02-21 |
| 2024-06-28 | $37.00K 10-Q · filed 2024-08-07 | $74.00K 10-Q · filed 2024-08-07 | $111.00K derived: sum of 3 quarters · filed 2025-02-21 | $148.00K derived: sum of 4 quarters · filed 2025-02-21 |
| 2024-03-29 | $37.00K 10-Q · filed 2024-05-07 | $74.00K derived: sum of 2 quarters · filed 2025-02-21 | $111.00K derived: sum of 3 quarters · filed 2025-02-21 | $149.00K derived: sum of 4 quarters · filed 2025-02-21 |
| 2023-12-29 | $37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | $74.00K derived: sum of 2 quarters · filed 2025-02-21 | $112.00K derived: sum of 3 quarters · filed 2025-02-21 | $151.00K 10-K · filed 2025-02-21 |
| 2023-09-29 | $37.00K 10-Q · filed 2024-10-30 | $75.00K derived: sum of 2 quarters · filed 2024-10-30 | $114.00K 10-Q · filed 2024-10-30 | $153.00K derived: sum of 4 quarters · filed 2025-02-21 |
| 2023-06-30 | $38.00K 10-Q · filed 2024-08-07 | $77.00K 10-Q · filed 2024-08-07 | $116.00K derived: sum of 3 quarters · filed 2025-02-21 | $155.00K derived: sum of 4 quarters · filed 2025-02-21 |
| 2023-03-31 | $39.00K 10-Q · filed 2024-05-07 | $78.00K derived: sum of 2 quarters · filed 2025-02-21 | $117.00K derived: sum of 3 quarters · filed 2025-02-21 | $156.00K derived: sum of 4 quarters · filed 2025-02-21 |
| 2022-12-30 | $39.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | $78.00K derived: sum of 2 quarters · filed 2025-02-21 | $117.00K derived: sum of 3 quarters · filed 2025-02-21 | $160.00K 10-K · filed 2025-02-21 |
| 2022-09-30 | $39.00K 10-Q · filed 2023-11-06 | $78.00K derived: sum of 2 quarters · filed 2023-11-06 | $121.00K 10-Q · filed 2023-11-06 | $133.00K derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-07-01 | $39.00K 10-Q · filed 2023-08-02 | $82.00K 10-Q · filed 2023-08-02 | $94.00K derived: sum of 3 quarters · filed 2024-02-27 | $109.00K derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-04-01 | $43.00K 10-Q · filed 2023-05-03 | $55.00K derived: sum of 2 quarters · filed 2024-02-27 | $70.00K derived: sum of 3 quarters · filed 2024-02-27 | $90.00K derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $27.00K derived: sum of 2 quarters · filed 2024-02-27 | $47.00K derived: sum of 3 quarters · filed 2024-02-27 | $83.00K 10-K · filed 2024-02-27 |
| 2021-10-01 | $15.00K 10-Q · filed 2022-11-02 | $35.00K derived: sum of 2 quarters · filed 2022-11-02 | $71.00K 10-Q · filed 2022-11-02 | $115.00K derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-07-02 | $20.00K 10-Q · filed 2022-08-10 | $56.00K 10-Q · filed 2022-08-10 | $100.00K derived: sum of 3 quarters · filed 2023-02-23 | $148.00K derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-04-02 | $36.00K 10-Q · filed 2022-05-04 | $80.00K derived: sum of 2 quarters · filed 2023-02-23 | $128.00K derived: sum of 3 quarters · filed 2023-02-23 | $178.00K derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-01-01 | $44.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $92.00K derived: sum of 2 quarters · filed 2023-02-23 | $142.00K derived: sum of 3 quarters · filed 2023-02-23 | $259.00K 10-K · filed 2023-02-23 |
| 2020-10-02 | $48.00K 10-Q · filed 2021-11-03 | $98.00K derived: sum of 2 quarters · filed 2021-11-03 | $215.00K 10-Q · filed 2021-11-03 | $352.00K derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-07-03 | $50.00K 10-Q · filed 2021-08-04 | $167.00K 10-Q · filed 2021-08-04 | $304.00K derived: sum of 3 quarters · filed 2022-02-23 | $445.00K derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-04-03 | $117.00K 10-Q · filed 2021-05-05 | $254.00K derived: sum of 2 quarters · filed 2022-02-23 | $395.00K derived: sum of 3 quarters · filed 2022-02-23 | $540.00K derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-01-03 | $137.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $278.00K derived: sum of 2 quarters · filed 2022-02-23 | $423.00K derived: sum of 3 quarters · filed 2022-02-23 | $584.00K 10-K · filed 2022-02-23 |
| 2019-09-27 | $141.00K 10-Q · filed 2020-11-04 | $286.00K derived: sum of 2 quarters · filed 2020-11-04 | $447.00K 10-Q · filed 2020-11-04 | |
| 2019-06-28 | $145.00K 10-Q · filed 2020-08-05 | $306.00K 10-Q · filed 2020-08-05 | ||
| 2019-03-29 | $161.00K 10-Q · filed 2020-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |